Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Subarachnoid Hemorrhage | 20 | 2024 | 1022 | 1.620 |
Why?
|
Intracranial Aneurysm | 21 | 2023 | 1272 | 1.530 |
Why?
|
Aneurysm, Ruptured | 13 | 2018 | 456 | 1.180 |
Why?
|
Vasospasm, Intracranial | 7 | 2024 | 206 | 0.990 |
Why?
|
Hibernation | 8 | 2001 | 48 | 0.800 |
Why?
|
Cerebral Angiography | 17 | 2016 | 1262 | 0.780 |
Why?
|
Embolization, Therapeutic | 8 | 2018 | 1403 | 0.690 |
Why?
|
Moyamoya Disease | 3 | 2022 | 273 | 0.640 |
Why?
|
Neurosurgical Procedures | 12 | 2024 | 2074 | 0.590 |
Why?
|
Angiography, Digital Subtraction | 6 | 2021 | 332 | 0.560 |
Why?
|
Endovascular Procedures | 7 | 2018 | 2222 | 0.530 |
Why?
|
Sciuridae | 8 | 2001 | 79 | 0.400 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2012 | 9 | 0.400 |
Why?
|
Posterior Cerebral Artery | 1 | 2012 | 34 | 0.390 |
Why?
|
Cerebral Arterial Diseases | 1 | 2012 | 82 | 0.390 |
Why?
|
Cerebrovascular Disorders | 4 | 2013 | 1470 | 0.380 |
Why?
|
Stents | 4 | 2016 | 3213 | 0.370 |
Why?
|
Cerebral Revascularization | 4 | 2022 | 260 | 0.340 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 629 | 0.310 |
Why?
|
Brain Ischemia | 7 | 2020 | 3000 | 0.260 |
Why?
|
Spinal Neoplasms | 1 | 2012 | 708 | 0.260 |
Why?
|
Preoperative Care | 2 | 2019 | 2267 | 0.240 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2022 | 360 | 0.230 |
Why?
|
Catheterization | 1 | 2009 | 1425 | 0.220 |
Why?
|
Pituitary Neoplasms | 1 | 2012 | 1321 | 0.220 |
Why?
|
Surgical Instruments | 5 | 2013 | 377 | 0.210 |
Why?
|
Adenoma | 2 | 2014 | 2152 | 0.200 |
Why?
|
rho-Associated Kinases | 1 | 2024 | 291 | 0.200 |
Why?
|
Adaptation, Physiological | 3 | 1999 | 1308 | 0.180 |
Why?
|
Microsurgery | 2 | 2017 | 795 | 0.170 |
Why?
|
Malpractice | 1 | 2024 | 561 | 0.160 |
Why?
|
Carotid Artery, Internal | 2 | 2007 | 437 | 0.160 |
Why?
|
Peptide Chain Elongation, Translational | 1 | 1998 | 31 | 0.160 |
Why?
|
Postoperative Complications | 6 | 2017 | 15747 | 0.150 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1998 | 100 | 0.150 |
Why?
|
Middle Aged | 40 | 2024 | 223004 | 0.150 |
Why?
|
Carotid Stenosis | 2 | 2019 | 861 | 0.150 |
Why?
|
Neuronavigation | 1 | 2019 | 167 | 0.140 |
Why?
|
Blood Glucose | 4 | 2020 | 6425 | 0.140 |
Why?
|
Hospital Mortality | 5 | 2018 | 5343 | 0.140 |
Why?
|
Treatment Outcome | 17 | 2022 | 65189 | 0.130 |
Why?
|
Aneurysm | 2 | 2013 | 337 | 0.130 |
Why?
|
Cross Infection | 2 | 2016 | 1427 | 0.130 |
Why?
|
Male | 47 | 2024 | 363691 | 0.130 |
Why?
|
Imaging, Three-Dimensional | 7 | 2019 | 4034 | 0.130 |
Why?
|
Female | 46 | 2024 | 396101 | 0.130 |
Why?
|
Cerebrovascular Circulation | 4 | 1999 | 2673 | 0.130 |
Why?
|
Adult | 29 | 2024 | 223038 | 0.120 |
Why?
|
Ribosomes | 1 | 1998 | 493 | 0.120 |
Why?
|
Brain Injuries | 3 | 1999 | 2060 | 0.120 |
Why?
|
Aneurysm, False | 2 | 2014 | 264 | 0.120 |
Why?
|
Aged | 28 | 2024 | 171114 | 0.120 |
Why?
|
Tracheostomy | 1 | 2018 | 429 | 0.120 |
Why?
|
Humans | 60 | 2024 | 765956 | 0.110 |
Why?
|
Retrospective Studies | 17 | 2022 | 81515 | 0.110 |
Why?
|
Endarterectomy, Carotid | 1 | 2019 | 557 | 0.110 |
Why?
|
Basal Ganglia Cerebrovascular Disease | 1 | 2013 | 7 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 10 | 2019 | 20660 | 0.110 |
Why?
|
Stroke | 5 | 2020 | 9747 | 0.110 |
Why?
|
Epistaxis | 1 | 2014 | 119 | 0.110 |
Why?
|
Platelet Activating Factor | 2 | 1990 | 142 | 0.110 |
Why?
|
Cerebral Arteries | 2 | 2013 | 490 | 0.110 |
Why?
|
Anterior Cerebral Artery | 1 | 2013 | 49 | 0.110 |
Why?
|
Thrombolytic Therapy | 1 | 2002 | 2059 | 0.110 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2013 | 36 | 0.110 |
Why?
|
Sphenoid Bone | 1 | 2014 | 176 | 0.110 |
Why?
|
Cerebral Hemorrhage | 3 | 2014 | 2648 | 0.100 |
Why?
|
Brain | 10 | 2014 | 27178 | 0.100 |
Why?
|
Aspirin | 2 | 2016 | 3134 | 0.100 |
Why?
|
Fluoroscopy | 2 | 2016 | 947 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 318 | 0.100 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2016 | 2770 | 0.100 |
Why?
|
Jugular Veins | 1 | 2013 | 211 | 0.100 |
Why?
|
Nerve Tissue Proteins | 3 | 1999 | 4392 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3584 | 0.090 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2013 | 142 | 0.090 |
Why?
|
Protein Biosynthesis | 1 | 1998 | 2086 | 0.090 |
Why?
|
Angioplasty | 1 | 2014 | 352 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1603 | 0.090 |
Why?
|
Autoradiography | 3 | 1998 | 723 | 0.090 |
Why?
|
Peptide Elongation Factor 2 | 2 | 2001 | 17 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 2 | 2019 | 1426 | 0.090 |
Why?
|
Preoperative Period | 1 | 2012 | 566 | 0.090 |
Why?
|
Glucose | 3 | 1999 | 4335 | 0.080 |
Why?
|
Rupture, Spontaneous | 3 | 2017 | 359 | 0.080 |
Why?
|
Risk Management | 1 | 2013 | 559 | 0.080 |
Why?
|
Glomus Jugulare Tumor | 1 | 2009 | 35 | 0.080 |
Why?
|
Ear, Inner | 1 | 2013 | 425 | 0.080 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 805 | 0.080 |
Why?
|
Lactates | 1 | 1990 | 398 | 0.080 |
Why?
|
Carotid Body Tumor | 1 | 2009 | 32 | 0.080 |
Why?
|
Clostridium Infections | 1 | 2016 | 564 | 0.080 |
Why?
|
Risk Factors | 16 | 2021 | 74836 | 0.080 |
Why?
|
Cerebral Veins | 1 | 1990 | 157 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2643 | 0.080 |
Why?
|
Length of Stay | 6 | 2019 | 6485 | 0.080 |
Why?
|
MicroRNAs | 1 | 2024 | 3785 | 0.080 |
Why?
|
Hippocampus | 2 | 1999 | 3775 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9524 | 0.080 |
Why?
|
Intracranial Embolism | 1 | 2009 | 189 | 0.070 |
Why?
|
Young Adult | 9 | 2019 | 59886 | 0.070 |
Why?
|
North America | 2 | 2022 | 1285 | 0.070 |
Why?
|
Hospitals, University | 1 | 2009 | 574 | 0.070 |
Why?
|
Radiography, Interventional | 2 | 2007 | 1129 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3110 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2564 | 0.070 |
Why?
|
Cerebral Cortex | 3 | 2019 | 5767 | 0.070 |
Why?
|
Patient Readmission | 2 | 2019 | 3286 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3320 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1514 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1434 | 0.060 |
Why?
|
Rats, Inbred Strains | 3 | 1992 | 2077 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6599 | 0.060 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 587 | 0.060 |
Why?
|
Ophthalmic Artery | 1 | 2005 | 56 | 0.060 |
Why?
|
Blood Cells | 2 | 1999 | 307 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2013 | 1944 | 0.060 |
Why?
|
Ischemic Attack, Transient | 1 | 2009 | 870 | 0.060 |
Why?
|
Glioma | 1 | 2019 | 3493 | 0.060 |
Why?
|
Dura Mater | 1 | 2006 | 296 | 0.050 |
Why?
|
Prevalence | 1 | 2021 | 15839 | 0.050 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11501 | 0.050 |
Why?
|
Circle of Willis | 1 | 2023 | 76 | 0.050 |
Why?
|
Contrast Media | 2 | 2013 | 5329 | 0.050 |
Why?
|
Anticoagulants | 2 | 2016 | 4862 | 0.050 |
Why?
|
United States | 10 | 2024 | 72898 | 0.050 |
Why?
|
Injections, Intra-Arterial | 1 | 2002 | 181 | 0.050 |
Why?
|
Temporal Arteries | 1 | 2023 | 154 | 0.050 |
Why?
|
Middle Cerebral Artery | 1 | 2023 | 268 | 0.050 |
Why?
|
Basilar Artery | 2 | 2013 | 206 | 0.050 |
Why?
|
Vision, Ocular | 1 | 2005 | 457 | 0.050 |
Why?
|
Receptors, CXCR4 | 1 | 2006 | 728 | 0.050 |
Why?
|
Craniotomy | 1 | 2006 | 730 | 0.050 |
Why?
|
Smoking | 2 | 2015 | 9081 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 2013 | 1946 | 0.050 |
Why?
|
Incidence | 5 | 2021 | 21480 | 0.050 |
Why?
|
Angiography | 2 | 2005 | 1581 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15880 | 0.040 |
Why?
|
Awareness | 1 | 2005 | 653 | 0.040 |
Why?
|
Time Factors | 6 | 2021 | 40065 | 0.040 |
Why?
|
Infarction | 1 | 2022 | 246 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 490 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2019 | 9071 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2712 | 0.040 |
Why?
|
Hospitalization | 2 | 2016 | 10808 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2019 | 59488 | 0.040 |
Why?
|
Nature | 1 | 1999 | 15 | 0.040 |
Why?
|
Adenosine Diphosphate Ribose | 1 | 1998 | 70 | 0.040 |
Why?
|
Peptide Elongation Factors | 1 | 1998 | 59 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 936 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36532 | 0.040 |
Why?
|
Cohort Studies | 5 | 2013 | 41647 | 0.040 |
Why?
|
Azepines | 2 | 1990 | 327 | 0.040 |
Why?
|
Hydrocephalus | 2 | 2017 | 762 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2007 | 2475 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3251 | 0.040 |
Why?
|
Adolescent | 7 | 2019 | 88832 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 24283 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12057 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2013 | 4300 | 0.040 |
Why?
|
Cerebral Infarction | 2 | 2013 | 970 | 0.040 |
Why?
|
Operating Rooms | 1 | 2024 | 788 | 0.040 |
Why?
|
Rats | 5 | 1998 | 23707 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 1998 | 177 | 0.040 |
Why?
|
Neurosurgery | 1 | 2024 | 683 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 251 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2012 | 3181 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 1998 | 543 | 0.040 |
Why?
|
Leucine | 1 | 1998 | 546 | 0.030 |
Why?
|
Glutathione | 1 | 1999 | 588 | 0.030 |
Why?
|
Comorbidity | 3 | 2017 | 10563 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 1999 | 657 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 200 | 0.030 |
Why?
|
Odds Ratio | 2 | 2021 | 9649 | 0.030 |
Why?
|
Hypothermia | 1 | 1998 | 190 | 0.030 |
Why?
|
Animals | 14 | 2006 | 168759 | 0.030 |
Why?
|
Cell Movement | 2 | 2024 | 5194 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13266 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4274 | 0.030 |
Why?
|
Neurons | 2 | 1992 | 9524 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 345 | 0.030 |
Why?
|
Triazoles | 2 | 1990 | 897 | 0.030 |
Why?
|
Seizures | 2 | 2022 | 3000 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5197 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5876 | 0.030 |
Why?
|
Registries | 2 | 2021 | 8297 | 0.030 |
Why?
|
Deoxyglucose | 1 | 1995 | 321 | 0.030 |
Why?
|
Antipyrine | 1 | 1994 | 40 | 0.030 |
Why?
|
Age Factors | 3 | 2019 | 18380 | 0.030 |
Why?
|
Phosphorylation | 3 | 2001 | 8278 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 13075 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2006 | 2329 | 0.030 |
Why?
|
Species Specificity | 1 | 1998 | 2406 | 0.030 |
Why?
|
Cytoplasm | 1 | 1998 | 1500 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1996 | 576 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1223 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4526 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2020 | 896 | 0.020 |
Why?
|
Ibotenic Acid | 1 | 1992 | 59 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2024 | 10429 | 0.020 |
Why?
|
Nasal Cavity | 1 | 2014 | 307 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39194 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2022 | 1921 | 0.020 |
Why?
|
Biometry | 1 | 2015 | 571 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1996 | 791 | 0.020 |
Why?
|
Acute Disease | 1 | 2002 | 7232 | 0.020 |
Why?
|
Hemostasis | 1 | 2014 | 467 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 1998 | 1999 | 0.020 |
Why?
|
Health Facility Size | 1 | 2011 | 59 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 2016 | 912 | 0.020 |
Why?
|
Temperature | 1 | 1998 | 2226 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1995 | 2266 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9443 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2263 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1441 | 0.020 |
Why?
|
Patient Selection | 1 | 2002 | 4255 | 0.020 |
Why?
|
Diencephalon | 1 | 1990 | 54 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4353 | 0.020 |
Why?
|
Disease Management | 2 | 2015 | 2535 | 0.020 |
Why?
|
Regional Blood Flow | 2 | 1990 | 1478 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36385 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2858 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 8067 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 1998 | 8102 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2013 | 584 | 0.020 |
Why?
|
Telencephalon | 1 | 1990 | 142 | 0.020 |
Why?
|
Carotid Artery, External | 1 | 2009 | 37 | 0.020 |
Why?
|
Body Water | 1 | 1990 | 338 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1998 | 2423 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1990 | 655 | 0.020 |
Why?
|
Arteries | 1 | 2013 | 1118 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2006 | 15398 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 14652 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 2007 | 0.020 |
Why?
|
Permeability | 1 | 1990 | 726 | 0.020 |
Why?
|
Blood-Brain Barrier | 2 | 1996 | 1037 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4850 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 1915 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29921 | 0.020 |
Why?
|
Lasers | 1 | 1992 | 951 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12795 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1806 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2012 | 814 | 0.020 |
Why?
|
History, 21st Century | 1 | 2013 | 1574 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2024 | 11888 | 0.020 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 721 | 0.020 |
Why?
|
RNA, Messenger | 2 | 1998 | 12769 | 0.020 |
Why?
|
Oxygen | 1 | 1998 | 4241 | 0.020 |
Why?
|
Thromboembolism | 1 | 2012 | 1003 | 0.020 |
Why?
|
Behavior, Animal | 1 | 1994 | 1865 | 0.020 |
Why?
|
Chromatin | 1 | 1998 | 2980 | 0.020 |
Why?
|
Electromagnetic Phenomena | 1 | 2007 | 160 | 0.020 |
Why?
|
Radiotherapy | 1 | 2012 | 1494 | 0.020 |
Why?
|
Liver | 1 | 2001 | 7562 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2013 | 1181 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22222 | 0.020 |
Why?
|
Child | 2 | 2013 | 80563 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2016 | 1292 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21056 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3461 | 0.010 |
Why?
|
Insurance, Health | 1 | 2017 | 2520 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2006 | 431 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7599 | 0.010 |
Why?
|
Lactic Acid | 1 | 1990 | 1137 | 0.010 |
Why?
|
Perioperative Care | 1 | 2012 | 1055 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2006 | 416 | 0.010 |
Why?
|
Temporal Bone | 1 | 2009 | 683 | 0.010 |
Why?
|
Vision Tests | 1 | 2005 | 160 | 0.010 |
Why?
|
Models, Neurological | 1 | 2012 | 1747 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2006 | 455 | 0.010 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1882 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2011 | 2424 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6203 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10383 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12509 | 0.010 |
Why?
|
Elongation Factor 2 Kinase | 1 | 2001 | 10 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2013 | 4494 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2012 | 2098 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1998 | 7851 | 0.010 |
Why?
|
Optic Nerve | 1 | 2005 | 567 | 0.010 |
Why?
|
Software | 1 | 2015 | 4462 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5891 | 0.010 |
Why?
|
Dogs | 1 | 2006 | 3822 | 0.010 |
Why?
|
Electrocardiography | 1 | 1994 | 6404 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2001 | 327 | 0.010 |
Why?
|
Catalysis | 1 | 2001 | 770 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8501 | 0.010 |
Why?
|
Protein Phosphatase 2 | 1 | 2001 | 230 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10602 | 0.010 |
Why?
|
Models, Animal | 1 | 2006 | 2120 | 0.010 |
Why?
|
Cold Climate | 1 | 1998 | 7 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 6113 | 0.010 |
Why?
|
Ultrasonography | 1 | 1992 | 5993 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2006 | 11022 | 0.010 |
Why?
|
Cytosol | 1 | 2001 | 885 | 0.010 |
Why?
|
Electroencephalography | 1 | 1994 | 6273 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2006 | 3602 | 0.010 |
Why?
|
Protein Subunits | 1 | 2001 | 939 | 0.010 |
Why?
|
Neutrophils | 1 | 1990 | 3776 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7836 | 0.010 |
Why?
|
Blood Pressure | 1 | 1992 | 8532 | 0.010 |
Why?
|
HSP72 Heat-Shock Proteins | 1 | 1996 | 40 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5881 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 8927 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 14071 | 0.010 |
Why?
|
Hypertension | 1 | 2014 | 8626 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1996 | 564 | 0.010 |
Why?
|
Computer Simulation | 1 | 2007 | 6255 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1996 | 952 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1886 | 0.010 |
Why?
|
Microcirculation | 1 | 1996 | 1280 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26313 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13631 | 0.000 |
Why?
|
Microscopy, Fluorescence | 1 | 1996 | 2627 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12403 | 0.000 |
Why?
|
Rabbits | 1 | 1990 | 4734 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4427 | 0.000 |
Why?
|
Reference Values | 1 | 1990 | 4908 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17594 | 0.000 |
Why?
|
Spinal Cord Injuries | 1 | 1990 | 928 | 0.000 |
Why?
|
Spinal Cord | 1 | 1990 | 1784 | 0.000 |
Why?
|
Signal Transduction | 1 | 1998 | 23600 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1990 | 18294 | 0.000 |
Why?
|